Follow The Filings

CYTK position history

The shares of Cytokinetics (CYTK) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.

Equity, COM NEW

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q4: 48,000 shares, $2.2M, <0.01% of portfolio, New
  2. 2022 Q1: 38,000 shares, $1.4M, <0.01% of portfolio, Reduce −20.8%
  3. 2022 Q2: 28,000 shares, $1.1M, <0.01% of portfolio, Reduce −26.3%
  4. 2022 Q3: 28,000 shares, $1.4M, <0.01% of portfolio
  5. 2022 Q4: 44,100 shares, $2M, <0.01% of portfolio, Add +57.5%
  6. 2023 Q1: 48,100 shares, $1.7M, <0.01% of portfolio, Add +9.1%
  7. 2023 Q2: 40,000 shares, $1.3M, <0.01% of portfolio, Reduce −16.8%
  8. 2023 Q3: 25,000 shares, $737K, <0.01% of portfolio, Reduce −37.5%
  9. 2023 Q4: not held, Exit
  10. 2024 Q1: not held
  11. 2024 Q2: not held
  12. 2024 Q3: not held
  13. 2024 Q4: not held
  14. 2025 Q1: not held
  15. 2025 Q2: not held
  16. 2025 Q3: 24,500 shares, $1.3M, <0.01% of portfolio, New
  17. 2025 Q4: not held, Exit
  18. 2026 Q1: 23,000 shares, $1.5M, <0.01% of portfolio, New
  19. 2026 Q2: 10,000 shares, $852K, <0.01% of portfolio, Reduce −56.5%
Holdings date Value % of holdings Shares Filing date All 13F holders